Victrex (VCT) Given Buy Rating at Liberum Capital

Victrex (LON:VCT)‘s stock had its “buy” rating reiterated by research analysts at Liberum Capital in a research note issued to investors on Wednesday. They currently have a GBX 2,770 ($37.56) target price on the stock. Liberum Capital’s price objective indicates a potential upside of 9.40% from the company’s current price.

A number of other analysts have also weighed in on VCT. Deutsche Bank upped their target price on shares of Victrex from GBX 2,050 ($27.80) to GBX 2,200 ($29.83) and gave the stock a “hold” rating in a research note on Thursday, September 28th. Peel Hunt lowered shares of Victrex to a “hold” rating and set a GBX 2,300 ($31.19) target price on the stock. in a research note on Tuesday, October 31st. Barclays cut their target price on shares of Victrex from GBX 2,350 ($31.87) to GBX 2,270 ($30.78) and set an “equal weight” rating on the stock in a research note on Tuesday, November 28th. JPMorgan Chase & Co. upped their target price on shares of Victrex from GBX 2,250 ($30.51) to GBX 2,580 ($34.99) and gave the stock a “neutral” rating in a research note on Monday, January 8th. Finally, Berenberg Bank restated a “buy” rating and set a GBX 2,600 ($35.26) target price on shares of Victrex in a research note on Tuesday, December 5th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of GBX 2,309.80 ($31.32).

Shares of Victrex (VCT) opened at GBX 2,532 ($34.34) on Wednesday. The stock has a market cap of $2,180.00 and a PE ratio of 2,182.76. Victrex has a one year low of GBX 1,826 ($24.76) and a one year high of GBX 2,772 ($37.59).

In related news, insider Martin Court sold 441 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of GBX 2,618 ($35.50), for a total transaction of £11,545.38 ($15,656.88). Insiders have purchased 14 shares of company stock worth $36,018 over the last 90 days.

WARNING: “Victrex (VCT) Given Buy Rating at Liberum Capital” was published by BBNS and is the sole property of of BBNS. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://baseballnewssource.com/markets/victrex-vct-given-buy-rating-at-liberum-capital/1867572.html.

Victrex Company Profile

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.